Harmful blue light

"Harmful blue light" is not a molecule, protein, or receptor, but rather refers to a segment of the visible electromagnetic spectrum—specifically wavelengths between approximately 415 nm and 495 nm. Within this range, blue-violet light (415–455 nm) is considered particularly harmful to retinal cells due to its high photon energy. Excessive exposure can lead to photochemical damage in retinal pigment epithelial cells and photoreceptors by generating reactive oxygen species and promoting lipofuscin accumulation, which are implicated in age-related macular degeneration and other forms of retinal injury[1][3][5]. Blue-turquoise light (465–495 nm), while also part of the blue spectrum, plays essential roles in visual acuity and circadian rhythm regulation via melanopsin-containing photoreceptors; it is not considered harmful under normal conditions[1]. There are no drugs that "target" harmful blue light itself; instead, interventions include physical barriers such as filters or coatings on lenses. Because "harmful blue light" does not refer to any specific molecular entity or biological target but rather an environmental factor/physical property, it should not be classified as a therapeutic target. Any attempt to treat or modulate its effects focuses on protecting tissues from its impact rather than interacting with it as one would with an enzyme or receptor. In summary: Harmful blue light is not a canonical drug target—it is an environmental hazard defined by wavelength within the visible spectrum. It cannot be assigned standard molecular classifications nor does it have interacting drugs/mechanisms/biomarkers typical for biological targets.

Other names

Harmful blue lightBlue-violet light (for the most damaging sub-band)High-energy visible light (HEV)